ClinVar Miner

Submissions for variant NM_024592.5(SRD5A3):c.943C>T (p.Pro315Ser)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Neuberg Centre For Genomic Medicine, NCGM RCV004771711 SCV005382403 uncertain significance SRD5A3-congenital disorder of glycosylation 2023-05-20 criteria provided, single submitter clinical testing The observed missense c.943C>T(p.Pro315Ser) variant in SRD5A3 gene has been reported previously in homozygous state in individual(s) affected with Congenital disorders of glycosylation (CDG) (Kamarus Jaman et al., 2021). This variant is reported with the allele frequency of 0.006% in the gnomAD Exomes. The amino acid Pro at position 315 is changed to a Ser changing protein sequence and it might alter its composition and physico-chemical properties. The amino acid change p.Pro315Ser in SRD5A3 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. Multiple lines of computational evidence (Polyphen - Possibly Damaging, SIFT - Damaging, and MutationTaster - Disease causing) predict a damaging effect on protein structure and function for this variant. For these reasons, this variant has been classified as Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.